1. Market Research
  2. > Pharmaceutical
  3. > Generic Drug Market Trends
  4. > Fumarate De Formoterol-Drug Insights,2014

DelveInsight’s pharmaceuticals report, “Fumarate De Formoterol - Drug Insights, 2014” provides Fumarate De Formoterol marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed clinical assessment of the drug, patent details, route of synthesis, competitive landscape, and analysis of sales performance during the forecast period (2011-2015). The report also includes SWOT analysis for the drug. This report is built using data and information sourced from DelveInsight proprietary databases, primary and secondary research using Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by DelveInsight team of industry experts.

Data Sources
The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated drug.

Scope
- A review of the Fumarate De Formoterol based on information derived from company and industry-specific sources
- Coverage of the Marketed data of the Fumarate De Formoterol on the basis of MOA, target, dosage, route of administration, molecule type, strength, Chemical type and ATC Classification
- Coverage of the United States Drug Master File (US DMF), Active Substance Master File/EU DMF and API Manufactures in China & India for Schizophrenia drugs with location details
- Patent Expiry Timeline and Exclusivity Details
- Route of Synthesis of the API
- Global Forecasted Sales Figure from 2011-2015
- Qualitative and quantitative assessment of market space
- SWOT Analysis

Reasons to buy
- Evaluate the marketing status and exclusivity details of Fumarate De Formoterol to exploit opportunities for generic drug development opportunities.
- Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to Fumarate De Formoterol.
- API intelligence over Fumarate De Formoterol and gaining primary intelligence over Active Ingredients manufacturers across the globe.
- Understanding the chemical route of synthesis of Fumarate De Formoterol.
- Uncovering opportunities in the rapidly growing the US market
- Stay ahead of competition by understanding the changing competitive landscape
- Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential
- Make more informed business decisions from insightful and in-depth analysis of the drug’s performance
- Obtain sales forecast for currently marketed drug for 2011-2015

Table Of Contents

Fumarate De Formoterol-Drug Insights,2014
- Drug Overview
- Global Sales Assessment
- Product Description
- Mechanism of Action
- Pharmacodynamic Properties
- Pharmacokinetic Properties
- Marketed Details for the United States
- Marketed Details for the Europe
- Patent Information
- Patent and Exclusivity Expiry Assessment United States (US)
- Patent Numbers and Expiry Details
- Patent Details
- Route of Synthesis
- Global API Manufacturers Assessment
- The United States Drug Master File (US DMF)
- The Europe Drug Master File (EUDMF)/Active Substance Master File (ASMF)
- The Active Pharmaceutical Ingredient (API) Manufacturers in the ASIA Region
- The Active Pharmaceutical Ingredient (API) Manufacturers by the United States Drug Master (DMF) File Status
- The Active Pharmaceutical Ingredient (API) Manufacturers by Region
- The Active Pharmaceutical Ingredient (API) Manufacturers by Location/Countries
- Generic Players
- The Pipeline Coverage
- Clinical Trials Information
- Clinical Trials by Zone
- Company Profile
- Summary
- Company Financials
- SWOT Analysis
- References
- Appendix
- Methodology
- About DelveInsight
- Contact Us
- Disclaimer


List of Tables
- Fumarate De Formoterol, Market, Global Sales (in USD), 2014
- Fumarate De Formoterol, Description
- Fumarate De Formoterol, Marketed Details the United States (US)
- Fumarate De Formoterol, Marketed Details the Europe (EU)
- Fumarate De Formoterol, Patent/Exclusivity Expiry (Year), 2014
- Fumarate De Formoterol, Patent Number Specific Patent Expiry (Year), 2014
- Fumarate De Formoterol, Patent Details
- Fumarate De Formoterol, Route of Synthesis
- Fumarate De Formoterol, the United States Drug Master File (US DMF), 2014
- Fumarate De Formoterol, the Europe Drug Master File (EUDMF)/Active Substance Master File (ASMF), 2014
- Fumarate De Formoterol, the API Manufacturers, China, 2014
- Fumarate De Formoterol, the API Manufacturers, India, 2014
- Fumarate De Formoterol, the API Manufacturers by the US DMF Status, 2014
- Fumarate De Formoterol, the API Manufacturers by Region, 2014
- Fumarate De Formoterol, the API Manufacturers by Location/Countries, 2014
- Fumarate De Formoterol, Generic Players, 2014
- Fumarate De Formoterol, Pipeline Drug Details, 2014
- Fumarate De Formoterol, Clinical Trials, 2014
- Fumarate De Formoterol, Clinical Trials by Zone, 2014
- Company Overview, 2014
- Fumarate De Formoterol, SWOT Analysis, 2014
- Phase III Pipeline Therapeutics, 2014

List of Figures
- Fumarate De Formoterol, Market, Global Sales (in million USD), 2014
- Fumarate De Formoterol, Global Sales % Change, 2014
- Fumarate De Formoterol, Patent/Exclusivity Expiry (Year), 2014
- Fumarate De Formoterol, Patent Number Specific Patent Expiry (Year), 2014
- Fumarate De Formoterol, Route of synthesis
- Fumarate De Formoterol, the API Manufacturers by the US DMF Status (%), 2014
- Fumarate De Formoterol, the API Manufacturers by Region, 2014
- Fumarate De Formoterol, the API Manufacturers by Location/Countries, 2014
- Fumarate De Formoterol, Generic Players, 2014
- Fumarate De Formoterol, Clinical Trials by Zone (%), 2014

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Biosimilar - Global Market Outlook (2016-2022)

Biosimilar - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • September 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Biosimilars market is estimated to be $3.5 billion in 2015 with a CAGR of 23.8% is poised to reach $15.6 billion by 2022. High end adoption of off patented drugs ...

Insulin Biosimilars - Global Market Outlook (2016-2022)

Insulin Biosimilars - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • October 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Insulin Biosimilars market is accounted for $xx million in 2015 and is expected to reach $xx million by 2022 growing at a CAGR of xx% from 2015 to 2022. Growing ...

The Future of Generic Drugs and Strategies for Commercial Success

The Future of Generic Drugs and Strategies for Commercial Success

  • $ 2995
  • Industry report
  • September 2016
  • by CBR Pharma Insights

The Future of Generic Drugs and Strategies for Commercial Success Summary GBI Research’s latest report “The Future of Generic Drugs and Strategies for Commercial Success” discusses trends in the ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.